Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Pfizer’s PFE stock has declined 7.8% in the past month. Though the stock has been affected by declining sales of its COVID ...

Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive ...

Pfizer globally celebrated its 175 years. This milestone is not just a celebration of longevity but a testament to the ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with ...

Pfizer's Chris Boshoff outlines plans to prioritize high-return projects, with a focus on obesity, Oncology, and oral GLP-1 ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

A federal judge has ordered the U.S. Food and Drug Administration to publicly disclose more information underpinning its ...

Stocks knocked down in the first ten months of the year often suffer further damage as people sell for tax losses. But they ...

The company’s collaboration with German biotech BioNTech (Nasdaq: BNTX) on Comirnaty (tozinameran), one of the first ...

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer ...